Roche’s $1.8 Billion Acquisition of GenMark Diagnostics

Sidley Austin LLP and DLA Piper LLP advised Roche on the deal. Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics (NASDAQ: GNMK) announced that they have…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now